Chemoprevention of prostate cancer: Natural compounds, antiandrogens, and antioxidants - In vivo evidence
about
Tea consumption and prostate cancer: an updated meta-analysisAntiproliferative 4-(1,2,4-oxadiazol-5-yl)piperidine-1-carboxamides, a new tubulin inhibitor chemotype.Antioxidant treatment promotes prostate epithelial proliferation in Nkx3.1 mutant mice.A walnut-enriched diet reduces the growth of LNCaP human prostate cancer xenografts in nude miceFuture directions in the prevention of prostate cancer.Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial.Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells.Androgen receptor modulators: a marriage of chemistry and biology.Nutraceuticals for prostate cancer chemoprevention: from molecular mechanisms to clinical application.The pharmacodynamics of antiplatelet compounds in thrombosis treatment.Assessment of hormone-like activities in Ginkgo biloba, Elettaria cardamomum and Plantago ovata extracts using in vitro receptor-specific bioassays.Is There a Future for Chemoprevention of Prostate Cancer?Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1.Induction of reactive oxygen species generation inhibits epithelial-mesenchymal transition and promotes growth arrest in prostate cancer cellsLow prostate concentration of lycopene is associated with development of prostate cancer in patients with high-grade prostatic intraepithelial neoplasiaPotential role of gastrointestinal microbiota composition in prostate cancer risk.
P2860
Q21245600-8EF21A89-2211-4257-818A-4697964D7058Q30370844-F98DA59A-CF9D-46BD-9FEA-EBE58974DF21Q34450412-C4C2AC37-7CDF-4BBB-848D-69D00F8FEF85Q37007714-8DB8F818-8968-4F5C-9B7A-623626533897Q37279094-D8265334-D96D-4542-984B-C8AFAD953613Q37577822-480B8ADE-96A9-4E02-B669-9F48CD7677B0Q37650697-AC4C6ECB-E571-441D-B73A-4D7986A5E76BQ38116575-9233F242-2500-483B-9FB3-865DF60DCC0FQ38139567-110ED515-273B-410F-B2FE-64656C2711E7Q38800853-839E6900-4223-4D7B-B384-A94ADBC18A80Q38854576-CDC82FB4-326A-445D-8D77-58E3A6058D29Q38878301-9BC4D3E2-9DD7-459C-AAC1-142435C42E02Q38949811-868DA6A4-FE31-419B-AA6D-F300D73BEF8DQ39182893-50F9FE9D-6B90-4B1C-8E6A-18E0BE1121AEQ41902097-2E8E349A-17D6-43B4-9653-52D506314B8AQ42908744-79417947-955D-42E7-8CBC-A9435CD0F30A
P2860
Chemoprevention of prostate cancer: Natural compounds, antiandrogens, and antioxidants - In vivo evidence
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Chemoprevention of prostate ca ...... ntioxidants - In vivo evidence
@en
Chemoprevention of prostate ca ...... tioxidants - In vivo evidence.
@nl
type
label
Chemoprevention of prostate ca ...... ntioxidants - In vivo evidence
@en
Chemoprevention of prostate ca ...... tioxidants - In vivo evidence.
@nl
prefLabel
Chemoprevention of prostate ca ...... ntioxidants - In vivo evidence
@en
Chemoprevention of prostate ca ...... tioxidants - In vivo evidence.
@nl
P2860
P356
P1476
Chemoprevention of prostate ca ...... ntioxidants - In vivo evidence
@en
P2093
Maarten C Bosland
Nur Ozten-Kandaş
P2860
P356
10.4103/1477-3163.90438
P407
P577
2011-11-30T00:00:00Z